Patents by Inventor Menno Cornelis Franciscus Monnee

Menno Cornelis Franciscus Monnee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10766898
    Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: September 8, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10358448
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: July 23, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10351566
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: July 16, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10351565
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: July 16, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20190112311
    Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: December 17, 2018
    Publication date: April 18, 2019
    Applicant: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10155762
    Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: December 18, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20180327406
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 15, 2018
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20180327405
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 15, 2018
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20180291024
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10040797
    Abstract: The invention provides compounds of Formula 1: or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: August 7, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10040796
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: August 7, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 10040795
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: August 7, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Patent number: 9994572
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: June 12, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20170066767
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 9, 2017
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20170066770
    Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 9, 2017
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20170066769
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 9, 2017
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee
  • Publication number: 20170066768
    Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 9, 2017
    Inventors: BART DECORTE, JACOB CORNELIS RUSSCHER, MENNO CORNELIS FRANCISCUS MONNEE
  • Publication number: 20170066760
    Abstract: The invention provides compounds of Formula 1: or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 9, 2017
    Inventors: Bart DeCorte, Jacob Cornelis Russcher, Menno Cornelis Franciscus Monnee